Puravankara Limited confirmed the allotment of Non-Convertible Debentures (NCDs) through a private placement. The third tranche involves the issuance of 1,500 unlisted, unrated, secured, and redeemable NCDs, each with a face value of INR 10,00,000. This specific allotment aggregates to INR 150,00,00,000 (One Hundred and Fifty Crores). The date of allotment for this tranche was February 13, 2026, with a maturity period of 60 months from the deemed first allotment date.
Confirmation of Private Placement Allotment
Puravankara Limited has formally announced the successful allotment of Non-Convertible Debentures (NCDs) on a private placement basis, acting in furtherance of its earlier approval to raise funds up to INR 300,00,00,000. This latest action pertains to the allotment of the Third Tranche.
Details of the Third Tranche Issuance
The Management Sub-Committee of the Board sanctioned the allotment via Circular Resolution dated February 13, 2026. The key details of this specific issuance are:
- Total Number of NCDs: 1,500 (One Thousand Five Hundred).
- Nature: Unlisted, unrated, senior, secured, and redeemable NCDs.
- Face Value per Instrument: INR 10,00,000 (Indian Rupees Ten Lakhs Only) each, issued at par.
- Aggregate Allotment Value: INR 150,00,00,000 (Indian Rupees One Hundred and Fifty Crores only).
- Allotment Date: February 13, 2026.
- Tenure/Maturity: The instruments have a tenure of 60 months from the deemed date of first allotment, which is June 20, 2025.
Listing and Security Status
The issued NCDs are designated as unlisted and unrated. The instrument is classified as secured, and details concerning the charge/security created over the assets, coupon structure, and redemption manner are governed by the relevant PAS-4 documents circulated to the identified investors. No special rights, interests, or privileges are attached to these instruments, and no delays in interest or principal payment have been reported.
The company confirms that these NCDs are not proposed to be listed on any stock exchange.
Source: BSE
